Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

Share Price is delayed by 15 minutes
Get Live Data
262.50    -2.50 (-0.94%)
Bid:
260.00
Ask:
265.00
Spread: 5.00 (1.923%)
Market Cap: £127.20m
QTX Live PriceLast checked at - London Stock Exchange

Intraday Quartix Tech Share Chart

Directorate Changes

19 Feb 2024 07:00

RNS Number : 5033D
Quartix Technologies PLC
19 February 2024
 

Quartix Technologies plc

("Quartix", "the Group" or "the Company")

Directorate Changes

Quartix Technologies plc, a leading supplier of subscription-based vehicle tracking systems, analytical software and services is pleased to announce the appointment of Ian Spence as independent Non-Executive Director, effective from 19 February 2024. Ian will also Chair the Nomination Committee.

Ian has more than 25 years' experience in researching and advising companies in the technology sector. He is the Executive Chairman and Founder of Megabuyte, a leading company intelligence platform, delivering insights on the financial performance and corporate strategy of UK mid-market tech businesses.

Ian is recognized as one of the most established and respected financial analysts in the technology sector having been twice voted TechMARK Analyst of the Year, and also having been recognized twice by Debretts and The Sunday Times as one of the 20 most influential people in the technology sector in the United Kingdom.

Ian's other current roles include sitting as Non-Executive Director of Crown Place VCT PLC, a fund investing in early stage technology companies and as Principal at Agnosco Capital Ltd, where he provides research and strategic advice to technology companies and their investors.

Andy Walters, Executive Chairman, commented:

"We are delighted to announce Ian's appointment as an independent Non-Executive Director. Ian is one of the most distinguished tech analysts in the UK mid-market and we very much look forward to benefitting from his vast experience and market insight as we continue to execute on our growth strategy"

For further information, please contact:

Quartix (www.quartix.net)

Andy Walters, Executive Chairman

Emily Rees, Chief Financial Officer

01686 806 663

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

Matt Goode / Seamus Fricker / Trisyia Jamaludin (Corporate Finance)

Tim Redfern / Sunila de Silva (Corporate Broking)

020 7220 0500

 

--------------------------------------------------------------------------------------------------------------------------------------

INFORMATION REQUIRED UNDER RULE 17 AND SCHEDULE 2, PARAGRAPH (G) OF THE AIM RULES FOR COMPANIES ("AIM RULES")

Full name:

Ian Angus Spence

Age:

53

Shares held in the Company:

Nil

 

Current directorships and/or partnerships:

Historic directorships and/or partnerships (within the last five years):

 

Agnosco Capital Limited

 

Crown Place VCT plc

 

IS Research Ltd (T/A Megabuyte)

 

 

IX Acquisition Corp Inc

 

 

There is no further information to be disclosed in relation to the appointment pursuant to Rule 17 and Schedule 2, paragraph (g) of the AIM Rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAKAKFFPLEFA
Date   Source Headline
27th May 20214:25 pmRNSExercise of Share Options, PDMR Shareholding & TVR
25th May 20217:56 amRNSGranting of Options
21st May 20217:00 amRNSDirectorate Changes and Trading Update
26th Mar 20211:57 pmRNSExercise of Options, Director/PDMR Dealing & TVR
23rd Mar 20212:56 pmRNSResult of AGM
23rd Mar 20217:00 amRNSAGM Trading Statement
12th Mar 20211:34 pmRNSExercise of Options, Director/PDMR Dealing & TVR
4th Mar 20211:57 pmRNSExercise of share options and Total Voting Rights
3rd Mar 20217:00 amRNSDividend Timetable and Correction of Record Date
1st Mar 20217:00 amRNSFinal Results
20th Jan 202111:24 amRNSHolding(s) in Company
19th Jan 202111:24 amRNSResult of Secondary Placing
19th Jan 20217:00 amRNSProposed Secondary Placing
11th Jan 20217:00 amRNSTrading Statement
8th Jan 20215:15 pmRNSHolding(s) in Company
6th Jan 20213:11 pmRNSHolding(s) in Company
15th Dec 20204:40 pmRNSSecond Price Monitoring Extn
15th Dec 20204:35 pmRNSPrice Monitoring Extension
22nd Oct 20207:00 amRNSTrading Statement
24th Sep 20207:00 amRNSExercise of Options and Total Voting Rights
28th Jul 20207:00 amRNSInterim Results
17th Jul 20207:00 amRNSNotice of Interim Results
2nd Jun 20207:00 amRNSTrading Statement
27th Apr 20207:00 amRNSTrading Statement
30th Mar 20207:00 amRNSDirector/PDMR Shareholding
25th Mar 20201:10 pmRNSResult of AGM
24th Mar 202012:35 pmRNSExercise of Options and Issue of Equity
24th Mar 20207:00 amRNSAGM Trading Statement
19th Mar 20207:00 amRNSMeasures taken re Coronavirus and Dividend
9th Mar 20203:47 pmRNSPDMR Share Transfer
24th Feb 20207:00 amRNSFinal Results
13th Jan 20207:00 amRNSTrading Statement
23rd Oct 20197:00 amRNSDirectorate Changes
24th Jul 20197:00 amRNSInterim Results
19th Jun 20197:00 amRNSTrading Update
14th May 20198:58 amRNSDirector/PDMR Shareholding
10th May 20195:52 pmRNSHolding(s) in Company
15th Apr 201912:32 pmRNSDirector/PDMR Shareholding
15th Apr 20197:00 amRNSSenior Appointments
28th Mar 20198:43 amRNSDirector/PDMR Shareholding
26th Mar 20197:00 amRNSAGM Trading Statement
5th Mar 20197:00 amRNSHolding(s) in Company
25th Feb 20197:00 amRNSFinal Results
22nd Feb 20197:00 amRNSChange of Registered Office
30th Jan 20199:11 amRNSHolding(s) in Company
10th Jan 20197:00 amRNSTrading Statement
5th Dec 20187:00 amRNSExercise and Granting of Options
4th Dec 20187:00 amRNSTrading Statement
4th Oct 20187:00 amRNSBoard Update
13th Aug 20184:12 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.